HHS Secretary Robert F. Kennedy Jr has tasked the U.S. FDA with investigating the safety and efficacy of mifepristone, a drug used in medication abortions.
The probe comes in response to requests from many state attorneys general.
In a Sept. 19 letter to 22 state attorneys general that was recently made public, RFK Jr. and FDA Commissioner Marty Makary wrote the FDA would conduct “its own review of the evidence, including real-world outcomes and evidence, relating to the safety and efficacy of the drug.”
“This Administration will ensure that women’s health is properly protected by thoroughly investigating the circumstances under which mifepristone can be safely dispensed,” the letter added.
The generic version of mifepristone is manufactured by GenBioPro, while the brand name, Mifeprex, is made by Danco. A risk evaluation and mitigation strategy (REMS) is included in its labeling.
Dear readers: We recognize that politics often intersects with the financial news of the day, so we invite you to click here to join the separate political discussion.
